Ni L, Chen YW, de Brujin O. Towards understanding socially influenced vaccination decision making: an integrated model of multiple criteria belief modelling and social network analysis. Eur J Oper Res. 2021 Aug 16;293(1):276-89. doi: 10.1016/j.ejor.2020.12.011
John NM, Wright SJ, Gavan SP, Vass CM. The role of information provision in economic evaluations of non-invasive prenatal testing: a systematic review. Eur J Health Econ. 2019 Nov;20(8):1123-31. doi: 10.1007/s10198-019-01082-x
Wilson MR, Bergman A, Chevrou-Severac H, Selby R, Smyth M, Kerrigan MC. Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom. Eur J Health Econ. 2017 Mar;19(2):229-40. doi: 10.1007/s10198-017-0879-5.
Beard SM, von Scheele BG, Nuki G, Pearson IV. Cost-effectiveness of febuxostat in chronic gout. Eur J Health Econ. 2013 May;Advance online publication.
Brogan AJ, Stidham S. Non-separation in the mean-lower-partial-moment portfolio optimization problem. Eur J Oper Res. 2008 Jan;184(2):701-10.
Greiner W, Lehmann K, Earnshaw S, Bug C, Sabatowski R. Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany. Eur J Health Econ. 2006 Dec 1;7(4):290-6.
Lehmann K, Radbruch L, Gockel HH, Neighbors D, Nuyts G. Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Duragesic) with controlled release morphine. Eur J Health Econ. 2002;3:111-9. doi: 10.1007/s10198-002-0097-6.
Glass RL, Rothman KJ, Espinal F, Velez H, Smith NJ. Prevalence of human dental caries and water-borne trace metals. Arch Oral Biol. 1973 Sep;18(9):1099-104. doi: 10.1016/0003-9969(73)90083-6